Vistagen Therapeutics Files 8-K
Ticker: VTGN · Form: 8-K · Filed: Mar 6, 2025 · CIK: 1411685
| Field | Detail |
|---|---|
| Company | Vistagen Therapeutics, Inc. (VTGN) |
| Form Type | 8-K |
| Filed Date | Mar 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, financials
Related Tickers: VTGN
TL;DR
VTGN filed an 8-K on March 6th, mostly financial docs, nothing major yet.
AI Summary
Vistagen Therapeutics, Inc. filed an 8-K on March 6, 2025, reporting on events that occurred on March 3, 2025. The filing primarily concerns financial statements and exhibits, with no specific material events detailed in the provided text excerpt.
Why It Matters
This filing indicates Vistagen Therapeutics is providing updated financial information and exhibits to the SEC, which is standard for public companies but may contain details relevant to investors.
Risk Assessment
Risk Level: low — The provided text is a standard 8-K filing notification and does not contain information about significant risks or events.
Key Players & Entities
- Vistagen Therapeutics, Inc. (company) — Registrant
- 0001411685-25-000023 (filing_id) — Accession Number
- March 3, 2025 (date) — Earliest event reported
- March 6, 2025 (date) — Date of report
- 343 Allerton Ave. (address) — Principal executive offices
- South San Francisco, California 94080 (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Other Events and Financial Statements and Exhibits for Vistagen Therapeutics, Inc., with the earliest event reported being March 3, 2025.
When was this 8-K filed with the SEC?
This 8-K filing was made on March 6, 2025.
What is Vistagen Therapeutics, Inc.'s principal executive office address?
Vistagen Therapeutics, Inc.'s principal executive office is located at 343 Allerton Ave., South San Francisco, California 94080.
What is the company's state of incorporation?
Vistagen Therapeutics, Inc. is incorporated in Nevada.
What is the SIC code for Vistagen Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Vistagen Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 6, 2025 regarding Vistagen Therapeutics, Inc. (VTGN).